These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 22228726

  • 1. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J, Choi S, Lee JE, Lee HS, Sohn YH, Lee PH.
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
    [Abstract] [Full Text] [Related]

  • 2. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH.
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [Abstract] [Full Text] [Related]

  • 3. The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment.
    Kim SH, Kang HS, Kim HJ, Moon Y, Ryu HJ, Kim MY, Han SH.
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):122-7. PubMed ID: 22689705
    [Abstract] [Full Text] [Related]

  • 4. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G, Mouiha A, Duchesne S, Bocti C, Alzheimer's Disease Neuroimaging Initiative1.
    J Alzheimers Dis; 2015 Jun; 46(4):855-62. PubMed ID: 26402625
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT.
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Is white matter hyperintensity burden associated with cognitive and motor impairment in patients with parkinson's disease? A systematic review and meta-analysis.
    Carvalho de Abreu DC, Pieruccini-Faria F, Son S, Montero-Odasso M, Camicioli R.
    Neurosci Biobehav Rev; 2024 Jun; 161():105677. PubMed ID: 38636832
    [Abstract] [Full Text] [Related]

  • 9. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.
    González-Redondo R, Toledo J, Clavero P, Lamet I, García-García D, García-Eulate R, Martínez-Lage P, Rodríguez-Oroz MC.
    Eur J Neurol; 2012 Aug; 19(8):1100-7. PubMed ID: 22360775
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y, Nie K, Huang B, Mei M, Guo M, Xie S, Huang Z, Wang L, Zhao J, Zhang Y, Wang L.
    Neurosci Lett; 2017 Sep 29; 658():121-132. PubMed ID: 28823894
    [Abstract] [Full Text] [Related]

  • 13. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
    Kandiah N, Mak E, Ng A, Huang S, Au WL, Sitoh YY, Tan LC.
    Parkinsonism Relat Disord; 2013 Jul 29; 19(7):680-3. PubMed ID: 23623194
    [Abstract] [Full Text] [Related]

  • 14. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.
    J Neurol Neurosurg Psychiatry; 2012 Feb 29; 83(2):188-94. PubMed ID: 21890574
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE, Cho KH, Song SK, Kim HJ, Lee HS, Sohn YH, Lee PH.
    J Neurol Neurosurg Psychiatry; 2014 Jan 29; 85(1):7-16. PubMed ID: 23828835
    [Abstract] [Full Text] [Related]

  • 17. The white matter hyperintensities within the cholinergic pathways and cognitive performance in patients with Parkinson's disease after bilateral STN DBS.
    Liu Y, Wu L, Yang C, Xian W, Zheng Y, Zhang C, Hong G, Jiang L, Yang Z, Pei Z, Liu J, Chen L.
    J Neurol Sci; 2020 Nov 15; 418():117121. PubMed ID: 32950863
    [Abstract] [Full Text] [Related]

  • 18. Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status.
    Choi SH, Jung TM, Lee JE, Lee SK, Sohn YH, Lee PH.
    Neurobiol Aging; 2012 Jul 15; 33(7):1265-72. PubMed ID: 21220177
    [Abstract] [Full Text] [Related]

  • 19. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
    Wang L, Zhu XQ, Jiang CJ, Chen XW, Sun ZW.
    Zhonghua Yi Xue Za Zhi; 2013 Jan 15; 93(3):177-81. PubMed ID: 23570589
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.